Skip to main content
. 2019 May 13;18(1):792–803. doi: 10.3892/ol.2019.10348

Figure 8.

Figure 8.

Cytoplasmic expression of ERβ1 in patients with EGFR exon 21 L858R mutation is associated with survival. (A) Progression-free survival and (B) overall survival were significantly increased in patients with EGFR exon 21 L858R mutated non-small cell lung cancer and low cytoplasmic ERβ1 expression compared with high expression. P=0.005; P=0.002, respectively. Symbols represent censored observations. EGFR, epidermal growth factor receptor; ERβ1, estrogen receptor β1; cyto, cytoplasmic.